Detalles de la búsqueda
1.
Continuous Small Efforts Lead to Desirable Outcomes
Clinical Psychopharmacology and Neuroscience
; : 1-1, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-966702
2.
Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial
Clinical Psychopharmacology and Neuroscience
; : 135-146, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-966688
3.
Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression
Clinical Psychopharmacology and Neuroscience
; : 147-161, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-966687
4.
The Impact of COVID-19 on Psychiatric Health in the Korean Population
Clinical Psychopharmacology and Neuroscience
; : 410-418, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-1000111
5.
Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting
Clinical Psychopharmacology and Neuroscience
; : 594-598, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-1000095
6.
Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
Psychiatry Investigation
; : 268-280, 2022.
Artículo
en Inglés
| WPRIM | ID: wpr-926896
7.
Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
Clinical Psychopharmacology and Neuroscience
; : 233-242, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-897918
8.
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?
Clinical Psychopharmacology and Neuroscience
; : 434-448, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-897897
9.
Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
Clinical Psychopharmacology and Neuroscience
; : 233-242, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890214
10.
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?
Clinical Psychopharmacology and Neuroscience
; : 434-448, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890193
11.
Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics
Clinical Psychopharmacology and Neuroscience
; : 117-124, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-874488
12.
A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
Clinical Psychopharmacology and Neuroscience
; : 160-165, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-874483
13.
Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience
; : 243-253, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-897917
14.
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
Clinical Psychopharmacology and Neuroscience
; : 341-354, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-897907
15.
Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience
; : 243-253, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890213
16.
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
Clinical Psychopharmacology and Neuroscience
; : 341-354, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890203
17.
Possible Modulatory Role of ARC Gene Variants in Mood Disorders
Clinical Psychopharmacology and Neuroscience
; : 46-52, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-874496
18.
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia
Clinical Psychopharmacology and Neuroscience
; : 600-609, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-914082
19.
Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not? / 전남의대학술지
Chonnam Medical Journal
; : 157-165, 2020.
Artículo
| WPRIM | ID: wpr-831242
20.
Contribution of Personality Traits,Psychological Factors, and Health-Related Qualityof Life to Medication Adherence in Patientswith Rheumatoid Arthritis
Yonsei Medical Journal
; : 406-415, 2020.
Artículo
| WPRIM | ID: wpr-833371